Do liver chemistries and porphyrin fraction testing distinguish liver injury patterns and porphyria types?

Standard liver chemistry panels and specialized porphyrin fractionation serve as highly validated, evidence-based diagnostic pathways to categorize liver injuries and identify metabolic porphyria disorders.

Clinical classification of liver injury

Standard liver chemistry panels use ALT, AST, ALP, GGT, and bilirubin to characterize liver pathology. Clinical guidelines, such as those from the American College of Gastroenterology (ACG), utilize these enzyme values to calculate the R-ratio:

• Calculation: $\text{R-ratio} = (\text{ALT} / \text{ALT ULN}) / (\text{ALP} / \text{ALP ULN})$.
• Hepatocellular (R > 5): Indicated by primary, disproportionate elevations in ALT and AST.
• Cholestatic (R < 2): Indicated by predominant ALP elevation, indicating impaired bile flow. GGT testing is utilized alongside ALP to confirm hepatobiliary rather than bone origin.
• Mixed (R 2–5): Represents overlapping cellular and biliary injury.

Biochemical mapping of porphyrias

When initial screening detects abnormal urinary delta-aminolevulinic acid (ALA) or porphobilinogen (PBG), secondary fractionated porphyrin testing via high-performance liquid chromatography (HPLC) distinguishes specific porphyria subtypes across urine, feces, plasma, and erythrocytes:

• Porphyria Cutanea Tarda (PCT): Characterized by elevated urinary uroporphyrin and heptacarboxylate, and fecal isocoproporphyrin.
• Acute Intermittent Porphyria (AIP): Marked by high urinary ALA and PBG with minimal fecal porphyrin excretion.
• Hereditary Coproporphyria (HCP) and Variegate Porphyria (VP): HCP is distinguished by a massive excess of fecal coproporphyrin III, whereas VP features elevated fecal protoporphyrin and coproporphyrin III alongside a unique plasma fluorescence emission peak.

Bottom line

• Standard liver panels mathematically differentiate hepatocellular from cholestatic injury using the R-ratio, while secondary fractionated porphyrin testing provides a precise biochemical footprint across bodily media to diagnose distinct porphyria subtypes.